Miroslav S. Ravic
Chief Executive Officer presso MGB Biopharma Ltd.
Profilo
Miroslav S.
Ravic is the founder of MGB Biopharma Ltd.
(founded in 2010) and Pharma Integra Ltd.
(founded in 2005).
At MGB Biopharma Ltd., he holds the titles of CEO, Director, Chief Science & Medical Officer since 2011.
At Pharma Integra Ltd., he held the title of Managing Director.
His current jobs include being a Member at the American Society of Clinical Oncology, Inc., the American Society for Clinical Pharmacology & Therapeutics, and the British Pharmacological Society.
His former jobs include being the Chief Executive Officer at Antisoma Research Ltd.
from 2005 to 2005, Managing Director at Pharmaca Integrative Pharmacy, Inc., Executive Director at LipoNova AG in 2007, Director at Pharmsynthez PJSC, Principal at Boehringer Ingelheim GmbH, Head-Clinical Research & Development at Eisai Co., Ltd., Chief Clinical Officer at Sarossa Capital Ltd., and Chief Medical Officer at Affimed NV Niederlassung Deutschland from 2006 to 2012.
He obtained a doctorate degree from the University of London and holds graduate and doctorate degrees from the University of Belgrade.
Posizioni attive di Miroslav S. Ravic
Società | Posizione | Inizio |
---|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Chief Executive Officer | 19/04/2010 |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | 10/02/2011 |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Corporate Officer/Principal | 10/02/2011 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Precedenti posizioni note di Miroslav S. Ravic
Società | Posizione | Fine |
---|---|---|
LipoNova AG
LipoNova AG Medical/Nursing ServicesHealth Services The Company's principal activity is drug development. The Company is developer of effective therapies for diseases such as non-metastatic renal cell carcinoma (RCC). The Company also develops autologous tumour vaccines. | President | 01/01/2007 |
Antisoma Research Ltd. | President | 01/01/2005 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
EISAI CO., LTD. | Corporate Officer/Principal | - |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Chief Tech/Sci/R&D Officer | - |
Formazione di Miroslav S. Ravic
University of London | Doctorate Degree |
University of Belgrade | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EISAI CO., LTD. | Health Technology |
PHARMSYNTHEZ | Health Technology |
Aziende private | 11 |
---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Antisoma Research Ltd. | |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Pharmaca Integrative Pharmacy, Inc.
Pharmaca Integrative Pharmacy, Inc. Drugstore ChainsRetail Trade Pharmaca Integrative Pharmacy, Inc. operates as a pharmacy and health store. Its products includes facial care and makeup products, as well as beauty accessories; body care, hair care, bath and shower, sun care and bug spray, shaving and hair removal, hand and foot care, and kids and baby skin care and bath products; vitamins, supplements, minerals, sports and nutrition. The firm has offices in California, New Mexico, Oregon, and Washington. The company was founded by Don L. Summerfield, Dale Schwartz and Barry Perzow in June 2000 and is headquartered in Boulder, CO. | Retail Trade |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
LipoNova AG
LipoNova AG Medical/Nursing ServicesHealth Services The Company's principal activity is drug development. The Company is developer of effective therapies for diseases such as non-metastatic renal cell carcinoma (RCC). The Company also develops autologous tumour vaccines. | Health Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Commercial Services |
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
Pharma Integra Ltd.
Pharma Integra Ltd. Miscellaneous Commercial ServicesCommercial Services Pharma Integra Ltd. engages in scientific and technical activities. The company was founded on October 1, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Miroslav S. Ravic